Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog

In Vivo. 2008 Jan-Feb;22(1):47-9.

Abstract

Canine anal sac gland carcinoma (ASGC) is a frequently described neoplasm that is highly aggressive and can frequently lead to metastatic spread. In this paper, we describe the successful treatment of an incompletely excised ASGC by using cisplatin selectively driven within the tumor cells by trains of biphasic pulses. The dog received two courses of electrochemotherapy 14 days apart. Neither systemic nor local toxicities were detected during the whole course of therapy. The dog is still in complete remission after 18 months. Electrochemotherapy is a safe and efficacious adjuvant therapy for ASGC and warrants further investigation in order to standardize its protocols.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anal Gland Neoplasms / drug therapy*
  • Anal Gland Neoplasms / pathology
  • Anal Gland Neoplasms / surgery
  • Anal Sacs / drug effects*
  • Anal Sacs / pathology
  • Anal Sacs / surgery
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cisplatin / therapeutic use*
  • Combined Modality Therapy
  • Disease-Free Survival
  • Dog Diseases / drug therapy*
  • Dog Diseases / pathology
  • Dog Diseases / surgery
  • Dogs
  • Electrochemotherapy*
  • Male
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Cisplatin